Articles by Anna T. Levy, DO

Anna T. Levy, DO, discuses the safety profile and appropriate dosing of cabozantinib in patients with hepatocellular carcinoma.

Anna T. Levy, DO, discuses future research directions for lenvatinib in patients with hepatocellular carcinoma.